Pharmacy Benefit Management- What You Should Kno · ‒CVS to acquire Aetna ‒Prime Therapeutics...
Transcript of Pharmacy Benefit Management- What You Should Kno · ‒CVS to acquire Aetna ‒Prime Therapeutics...
9/12/2018
1
Pharmacy Benefit Management-What You Should KnowTina Rydland, PharmDManaging DirectorArdentCare Solutions
September 20, 2018
Nice to Be Home!
Learning outcomes
Care managers, claims managers and others will have a high level understanding PBM contracting and understand their role as liaisons/advocates in coordinating care with vendors to support members & clients
Objectives
• Understand core role of a Pharmacy Benefit Manager (PBM)
• Learn about current state of affairs
• Understand how two main PBM contract types work and impact the Plan
• Speak to myths regarding ways to contract and manage PBM program
• Obtain a few tips on how to gain control of the PBM contract(s)
• Explore how medical management might help pharmacy leaders to address new challenges in pharmacy
• Wind down with food for thought- is your pharmacy program up to snuff?
9/12/2018
2
WHAT IS A PBM?
Pharmacy Benefit Managers (PBMs) administer prescriptiondrug plans for more than 266 million Americans who havehealth insurance from a variety of sponsors including:commercial health plans, self-insured employer plans, unionplans, Medicare Part D plans, the Federal Employees HealthBenefits Program (FEHBP), state government employee plans,managed Medicaid plans, and others.
Source: Pharmaceutical Care Management Association (PCMA) https://www.pcmanet.org/our-industry/. PCMA is PBM trade organization
WHAT DO PBMS DO?
• PBMs reduce drug costs by: Offering Amazon-style home delivery of medications and creating select
networks of more affordable pharmacies; Encouraging the use of generics and more affordable brand
medications; Negotiating rebates from drug manufacturers and discounts from
drugstores; Managing high-cost specialty medications; and Reducing waste and improving adherence
Source: Pharmaceutical Care Management Association (PCMA) https://www.pcmanet.org/our-industry/
Over $400 Billion Prescription Drug Industry
PBM Current State of Affairs
Treacherous As
Paddle Boarding
Racing
in Colorado
9/12/2018
3
CVS Health Website
Express Scripts Website
“Finally, we used our cash flow to return $6.4
billion to shareholders through share repurchases
and dividends in 2017.” http://investors.cvshealth.com/2017-
in-review/ceo-shareholder-letterOptumRx, United Health Group WebsiteIn 2017, OptumRx revenues increased 5.5 % to $63.8 billion year over year. OptumRx fulfilled 1.3 billion adjusted scripts in 2017. https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2017/UNH-Q4-2017-Release.pdf
KEY POINT: BIG 4 PBMS DOMINATE, 286 MILLION MEMBERS
We’ve grown to serve 22 Blue Plans and more than 27 million members
Key Point: Big PBMs Dominate Rx Revenue,$228 B
See appendix for M&A History of PBMs
Thanks to Drug Channels Institute andAdam Fein for permission to use this chart.Source: The 2017 Economic Report on U.S.Pharmacies and Pharmacy BenefitManagers. Drug Channels.net
Continued ConsolidationMonitor Drug Prices
Significant Business Deals: 2017/2018‒CVS to acquire Aetna‒Prime Therapeutics 10-yr partnership w/ Walgreens‒Cigna acquires Express Scripts PBM ‒Albertsons trying to buy > 2,000 Rite Aid stores‒Walgreen Boots Alliance purchased >2000 Rite Aid stores‒Walmart acquires Humana‒Diplomat specialty pharmacy purchased small PBMs (LDI,NPS)‒Amazon’s acquires PillPack
Current State of Affairs
9/12/2018
4
Strip Packs- Simplify Medication Process
• Capture complete medication list • Synchronize refills• Packages medications in strip packs
by dose, e.g., AM, noon, evening, bedtime
• Pharmacy works closely w/ doctor• Medications subject to dosage
adjustments filled in vials• Strips delivered- usually monthly
Concentrated MarketMonitor Drug Prices
• Top three PBMs, pharmaceutical wholesalers, & retailers account for 85%, 66% and 49% of their markets, respectively1
• Top 4 specialty pharmacies owned/co-owned by a PBM ; accounted for ~ two-thirds specialty prescription revenues, 2017
2
• Owners: CVS Health, Express Scripts, Walgreens Boots Alliance (Alliance w Prime Therapeutics PBM), OptumRx
Current State of Affairs
1Source: USC Schaeffer Center, June 2017 BY NEERAJ SOOD; HTTP://EVIDENCEBASE.USC.EDU/FOLLOW-THE-MONEY-THE-FLOW-OF-FUNDS-IN-THE-
PHARMACEUTICAL-DISTRIBUTION-SYSTEM/12015 Market share by number of prescriptions for PBMs, by revenue for retailers
12014 Market share by revenue for wholesalers2
Source: https://www.drugchannels.net/2018/03/the-top-15-specialty-pharmacies-of-2017.html
Traditional Contract: Rx Reimbursement ModelPBM Largely Controls Flow of Dollars
Plan Sponsors gain control by using a pass-through, transparent contract
PBM retains undisclosed $ from transactions- passes % to plan sponsor.
Big PBM owned pharmacies= >50% of revenue; 2/3rds of specialty pharmacy revevnue
Tina Rydland added Circles to demonstrate a point and green arrow from pharmacy to PBM
Thanks to Drug Channels Institute, Adam Fein for permission to use chart.
9/12/2018
5
Current State of Affairs
Is Your Plan Paying Too Much?
Understand How PBM’s Work
9/12/2018
6
Key Point: Two Main PBM Contract Models
PBM Knowledge
Pass-through
Contract
Transparent
Plan pays PBM an administration fee
Gaining popularity
Traditional
Contract
Less Transparent
Plan pays zero/ reduced admin. fee AND PBM
retains % of $ from claims utilization
Most common; under fire for NOT passing
along savings to patients, tax payers
Know How Your PBM
Gets Paid and By How Much
23% Not Sure How PBM Gets PaidRisk of Overpaying
Source: 2016 PBMI Research Report
Wowzer! Respondents declared responsibility for organization’s prescription drug benefit
PBM Knowledge
Key Point: Pass–Through PBM Contract -Fully Transparent
PBM Knowledge
9/12/2018
7
Key Point: Traditional PBM Contract- Less Transparent
PBM Knowledge
Spread Pricing (Traditional Contract)1. Spread pricing on a prescription claims
• PBM bills insurer $100 for Rx
• PBM pays pharmacy $90 (certain %)
• PBM retains $10 (difference)
2. Spread on manufacturer revenue
• PBM receives $4 (e.g., % of wholesale cost) per rebated drug
• PBM passes zero or a percentage of $4 to Plan Sponsor
• PBM retains $4 or the difference
3. Pharmacy network fees
• PBM charges pharmacies to participate in network
4. PBM-owned pharmacies (retail, mail or specialty)
• PBM receives purchase discounts from wholesalers / mfrs.
• PBM charges Plans Sponsor non-discounted cost of drug
• PBM retains discount amount
Key Point: Alternatively, a True Pass-Through PBM Contract passes through to Plan Sponsor ALL achievable discounts and savings
Traditional PBM Contract- Less TransparentMisalignment Between PBM and Plan Sponsor
$$$$ PBM Revenue from
Pharmaceutical Company & Pharmacy network and owned
pharmacies
$
PBM Revenue from Plan Sponsor
(Administrative Fee)
PBM favors this
relationship to maintain
profit margins
9/12/2018
8
Misaligned PBM Contract Can Result in Plan Paying up to 30% Higher Drug Costs
Plan Sponsor’s Gross Drug Costs
Plan Sponsor’s Gross Drug Costs
Traditional Contract- Misaligned incentives, PBM favors mfr. and pharmacy relationships. Incentive to maintain profits by allowing coverage of higher cost drugs and higher utilization
Pass-through Contract- Aligned incentives, PBM does not profit from mfr. nor pharmacy relationships- results in use of lower cost drugs, lower utilization (aligned formulary and clinical programs)
Typical Consultant’s ReportEvaluating Claims Against Performance to Contractual Percentage Discount Guarantees
Useless Exercise if Plan
is Already Paying Too
Much! Grrr!
Achieve Lowest Net Drug Cost Model Optimize Formulary, Clinical Programs, Rebates in That Order
9/12/2018
9
Plans Switched to Pass-Through Contract, 2017Example of Savings Potential
Incumbent PBM
Pass-through PBM
Dru
g C
ost
s (p
er m
emb
er p
er m
on
th)
Gain Control
Claims Data: Prices Vary by Pharmacy
NDCPackage Size of NDC
Drug Name and Strength Pharmacy Chain NameCost Type
CodeAWP (List
Price)Ingredient
Costcost per unit
16714068303 1000SIMVASTATIN TAB 20MG 605 - NATIONAL ESN NETWOR MAC $442.80 $3.30 $0.04
16714068303 1000SIMVASTATIN TAB 20MG 605 - NATIONAL ESN NETWOR MAC $432.89 $12.00 $0.13
16714068303 1000SIMVASTATIN TAB 20MG 605 - NATIONAL ESN NETWOR MAC $432.89 $12.00 $0.13
16729000515 90SIMVASTATIN TAB 20MG GOOD NEIGHBOR PHCY PROVID MAC $441.15 $12.00 $0.13
16729000517 1000SIMVASTATIN TAB 20MG 605 - NATIONAL ESN NETWOR MAC $442.54 $2.88 $0.03
16729000517 1000SIMVASTATIN TAB 20MG 605 - NATIONAL ESN NETWOR MAC $442.54 $12.00 $0.13
16729000517 1000SIMVASTATIN TAB 20MG 605 - NATIONAL ESN NETWOR MAC $442.54 $12.00 $0.13
16729000517 1000SIMVASTATIN TAB 20MG HY-VEE INC MAC $442.54 $12.00 $0.13
68180047902 90SIMVASTATIN TAB 20MG TARGET CORPORATION MAC $442.85 $24.00 $0.27
68180047902 90SIMVASTATIN TAB 20MG TARGET CORPORATION MAC $442.85 $24.00 $0.27
68180047902 90SIMVASTATIN TAB 20MG CVS PHARMACY MAC $442.85 $24.00 $0.27
68180047902 90SIMVASTATIN TAB 20MG CVS PHARMACY MAC $442.85 $24.00 $0.27
68180047902 90SIMVASTATIN TAB 20MG CVS PHARMACY MAC $442.85 $24.00 $0.27
68180047902 90SIMVASTATIN TAB 20MG CVS PHARMACY MAC $442.85 $24.00 $0.27
68180047903 1000SIMVASTATIN TAB 20MG SUPERVALU PHARMACIES INC MAC $442.85 $14.99 $0.17
68180047903 1000SIMVASTATIN TAB 20MG SUPERVALU PHARMACIES INC MAC $442.85 $2.88 $0.03
68180047903 1000SIMVASTATIN TAB 20MG SUPERVALU PHARMACIES INC MAC $442.85 $12.00 $0.13
68180047903 1000SIMVASTATIN TAB 20MG SUPERVALU PHARMACIES INC MAC $442.85 $12.00 $0.13
68180047903 1000SIMVASTATIN TAB 20MG SUPERVALU PHARMACIES INC MAC $442.85 $12.00 $0.13
68382006710 1000SIMVASTATIN TAB 20MG GOOD NEIGHBOR PHCY PROVID MAC $442.80 $12.00 $0.13
This pharmacy uses higher cost generic drug and charges plan more for it (added a multiplier to the price)
Negotiated amount
Grocery chain Pharmacy
PBM’s National Pharmacy Network ($12.00)
PBM Contract Language Spells it OutPermits PBM to Receive and Retain Undisclosed Revenue
Disclosure-Manufacturer Fees. PBM or affiliates may hold contracts with pharmaceutical
companies relating to products covered under this Agreement. In connection with such
contracts, PBM or affiliates may have financial relationship with pharmaceutical companies
and may receive, retain fees or other compensation from pharmaceutical companies for services
rendered and property provided to pharmaceutical companies, including, without limitation,
administration fees that range between one percent (1%) and four percent (4%) of the
Wholesale Acquisition Cost (WAC) of the products dispensed across PBM’s book of business.
In addition, PBM or affiliates may receive concurrent or retrospective discounts from
pharmaceutical companies which are attributable to or based on products purchased by PBM
affiliated dispensing pharmacies. The term “Rebates” does include manufacturer
administration fees received by PBM that are attributable to utilization of Client’s Plan
Participants, but does not include compensation, and discounts associated with purchase price
of products, which belong exclusively to PBM or its affiliates.
Financial Relationship w/ Pharmaceutical
Companies
9/12/2018
10
2.14 Drug Classification. PBM shall use only one nationally
recognized source, currently Medi-Span Master Drug Database
(Medi-Span) indicators and their associated files, or, if needed due
to limitations within the one source, PBM may use indicators
provided by another nationally available services to determine the
classification of drugs (e.g., prescriptions, OTC, brands, generics,
single sources, multi-source) for purposes of this agreement.
PBM Contract Language Spell it OutPBM Maximizes Profit by Classifying Claims in Their Favor
Vague Classification Source
Specific, reproducible definition
PBM RFP ResponsesPBM Maximizes Profit by Classifying Claims in Their Favor
Vague Generic Definition
Key Point: Stop using BAD PBM Contracts
Remove profit making opportunities & incentives
Demand transparent pricing
Demand downward pressure on drug costs
PBM Knowledge
9/12/2018
11
Americans’ Top Priority- Lower Drug Prices
Priority for Health and Human Services “…Detach the Incentives…”
“The key is, can we detach the incentives of everybody inthis system from these artificial list prices? ... [Rebates]ferment this game we have of ‘if list price goes up, rebategoes up’ where everybody’s winning except the patientwho’s paying out of pocket,”
HHS Secretary Alex Azar
Priority for These Guys! Employers Plan to Remove Profit-Making Incentives
The CEOs -- Jeff Bezos, Warren Buffett and Jamie Dimon --plan to start an insurance company for their employees thatwould be “independent entity free from profit-makingincentives and constraints.“Source:
SEATTLE & OMAHA, Neb. & NEW YORK--(BUSINESS WIRE)--Amazon (NASDAQ: AMZN), Berkshire Hathaway (NYSE: BRK.A, BRK.B) and JPMorganChase (NYSE: JPM) announced June 20, 2018
9/12/2018
12
Gain Control of
PBM Contract
Serene aspen grove in Colorado
Control of PBM Contract & Pharmacy
Spend
1. Trusted Advisor
2. Challenge Status Quo
3. Expert Analytics
4. Seek Maximum Achievable Discount
5. Contract(s)
Align to Plan’s
Interests
6. Address New
Challenges
7. Food for Thought-Strategic Decisions
7- Steps to Gain Control Of PBM Contract
Use Trusted AdvisorKnowledgeable, Unbiased
• Questions to ask your PBM consultantDo you get paid by PBMs or PBM affiliates for placing business? Generalist or expert in pharmacy benefits?Describe analytic capabilities, know how- go beyond the % discount
evaluation?How do you account business tactics that taint financial evaluation?What PBMs do you usually invite to RFP?How is process to assist Plan in narrowing in on right vendor(s)- financial &
serves?What is your success rate in changing PBM contract language to “level the
playing field”? How do you monitor PBM performance?
Gain Control
9/12/2018
13
Able and Willing to Change PBM Contract(s)Possible Action Steps w/ Advisor
Gain Control
Good Contract:
• Ongoing Monitoring
• Costs by channel, claim types, guarantees
• Plan/benefit
• Clinical mgt.
• Pipeline
• Resolve problems as they arise (don’t wait for Audit)
Poor Contract AND “Stuck” in Contract
• Analyze claims data
• Use data as leverage w/ PBM to:
• Stop the “bleed” e.g., generic pricing, mail order
• Exercise early exit clause
• Modify formulary
Poor Contract AND Near End of Contract
Terms
• Get educated
• Evaluate costs, slice and dice data, plan/benefit set-up
• Identify opportunities
• Explore all options
• Seek new contract -aligned to Plan’s best interest
Gain Control
Myth Facts
Bigger PBMs are better Smaller PBMs compete on price, service, compliance
Carve-in PBM is the way to go
Carve-in contract offers less control, strings attached; change all or nothing
Group purchasing better than direct purchasing
Group purchasing could cost more AND may not be a good match; evaluation is needed
PBM utilization management programs maximize Plan savings
PBM programs may favor manufacturer financial relationships Vs. plan sponsor cost containment goals
Challenge the Status Quo“Myths Buster”
Gain Control
Myth Fact
Bundling PBM services(single contract) is better e.g., mail, specialty pharmacy , core services
Select individual programs based on best fit, e.g., price, local Vs. national, better clinical mgt.; Option to change one service w/o disrupting others
Monitor performance of claims to contractual percentage discount guarantees
Monitoring variance to % discount guarantees is flawed! List price minus % discount is not what you actually pay!
DIY PBM is undoable Caterpillar, other payors use PBM to administer core functions; then in-source or use partner to handle formulary, UM, pharmacy network, etc.,
Challenge the Status Quo“Myths Buster”
9/12/2018
14
Caterpillar’s Reported DIY
Success
Limit PBM Involvement In Formulary and
Clinical Management
https://www.beckershospitalreview.com/supply-chain/can-employers-lower-drug-spending-by-limiting-pbm-involvement-in-health-plans-4-thoughts.html
Gain Control
• Estimated quarter of drug spend was wasted
1. Drug Waste
• Eliminates risk of PBM tactics as source of high drug costs
• Promoted use of generics instead of costly brands• Hired its own pharmacists and physicians
2. Created Own Formulary and Pharmacy Network
• Use PBM as an administrator only
3. Uses PBM to Process Claims and get Rebates
• Saves $5 to $10 million/year on cholesterol-lowering drugs alone
4. Success
Claims processing * Member / provider call center
Retail network management services * Prior authorization services *
Enrollment, eligibility management Reporting/ analytics *
Benefit plan design, management Drug Utilization Review (DUR) –retrospective *
Formulary management/ P&T * Mail pharmacy *
Rebate administration * Specialty pharmacy *
Client services Website
Communications- members, physicians
Drug Utilization Review (DUR) –concurrent
DIY- *PBM Roles Commonly Out-Sourced and/or Managed by Plan Sponsor
Gain Control
Ensure Data is Complete, AccurateDisclose Business Tactics that Taint Evaluation
MonitorKey
Metrics
Pricing Analysis-
include value of formulary, UM
Data Validation-is it accurate?
Data Capture-transaction
level
Key Points: Conduct ongoing monitoring of claims, correct problems right away, don’t wait! Don’t relay on PBM to monitor for you.
Gain Control
9/12/2018
15
• Realize actual savings Vs. better percentage discount rates only
• PBMs continuously negotiate for better drug discounts
• Demand to receive ALL discounts as they are negotiated
• Manage contract to discount “floor” (maximum achievable discount)
• DON’T manage contract to discount “ceiling” rate , PBM will keep difference as revenue
Gain Control
Receive Maximum Achievable Discounts from PBM
PBM ContractingAlignment to Plan’s Best InterestsContracting best practices
Clear definition of claimsRight to claims data
(transaction level, clinical indicators)
Right to audit all agreements w/ pharm. mfr. & pharmacy
Right to evaluate financials against market
Gain Control
Favorable contract terms
Overall favorable contract language
Clinically appropriate, lowest-net-cost therapies
High service commitment
Accountable to CMS compliance
Medical Management+
Pharmacy Leaders
Address New Challenges in Pharmacy
9/12/2018
16
Common ThemesEmployers Concerns with PBM
• No integrated case management despite PBM is carve in with Medical Benefit
• Specialty pharmacy management
• Poor formulary management
• No leading edge savings programs
Source: employer surveys, health business group
Address New Challenges
Oversight/In-source Cost Containment Programs and Explore Technology
• UM Programs
• Timely, use all available literature (not cherry picking to favor mfr. agreements), protocols enforced
• Fill gaps in pharmacist expertise: e.g., oncology, rare diseases, infectious diseases, renal care, behavioral health
• Explore value of technology used by network providers
• Special drug packaging- Simplify medication process for individuals, poly-chronic
• Help individuals remain independent• Accurate dosing tools, e.g., pharmacokinetics,
pharmacogenetics, guidelines• Improve dosing and data- e.g., hospital, infusion centers
Address New Challenges
Medical ManagementUncover Patient Concerns with Pharmacy Benefit
Perceived value— access, cost, service, outcomes
Look for patterns- e.g., member forgoes pharmacy benefit card—paying cash at counter is cheaper
Identify waste with 90 day supply program- auto-refills (patient stockpiles)
Impact of excessive promotion of mail order, PBM owned pharmacies; choice, access to pharmacist
Address New Challenges
9/12/2018
17
High Cost Drug RegimensIs Current Approach Working?
• Ineffective, unsafe medication therapy is costly
• Clinical information is limited, rare disease!
Current solutions from PBM, specialty pharmacy, Plan• Prior authorization – fax, phone, portal• Claim editing, re-pricing• Medical, pharmacy benefit rebates • Site of care management (hospital → home
infusion)
Address New Challenges
Food for Thought
Rawah Lakes Colorado
Are Patients Making Informed Medication Decisions? Who’s Helping Them?
“We’ve created a multi trillion-dollar edifice for dispensing the medicalequivalent of lottery tickets – and have only the rudiments of a systemto prepare patients for the near certainty that those tickets will not win.Hope is not a plan, but hope is our plan.”
Dr. Atul Gawande in his book, Being Mortal
Food for thought
9/12/2018
18
“As efforts to transform America’s health care delivery systemcontinue, patients must be both informed and actively engaged indecisions concerning the medications that represent the bestchoices for them in preventing and controlling disease. Thesedecisions can best be made when the cultural needs and beliefs ofthe patient are considered and incorporated with the bestknowledge and recommendations of the PCMH team members,particularly prescribers, pharmacists, care managers, and others,who provide and are responsible for the patient’s medicationrelated care.”
Comprehensive Medication Managmenthttps://www.pcpcc.org/sites/default/files/resources/Appendix_A_Guidelines_for_the_Practice_and_Documentation.pdf
Are Patients Making Informed Medication Decisions?
Food for thought
• Comprehensive Medication Management (CMM) ensures: Appropriate use, administration of medicationMedication is effectiveMedication is not causing harmPatient can adhere to drug regimenWorks DIRECTLY w/ individuals (patient, care
giver) AND care teamContinuous care processExperts
• Does this process have a role in value-based contracting?
Source: https://www.pcpcc.org/guide/patient-health-through-medication-management
Food for thought
Are Patients Making Informed Medication Decisions? Is CMM Missing?
Maximize ValueHigh Cost Drug Regimens
Patient: Informed Decisions, Actively Engaged
Drug Selection Decisions
Appropriate Dose, regimen
(pharmacogenetics –kinetics; pt.
characteristics, guidelines)
Lowest Cost Procurement (e.g.,
PBM , Specialty Pharmacy, Direct,
Health System)
Site of Administration (experience?)
Appropriate preparation,
administration (experience?)
My EOB/Bill: accurate?,
unexpected?
Monitoring, follow up care
(value assessment)
Many Stakeholders, who’s doing what, who’s aligned to patient/plan interests?
• PBM & Pharmacy Benefit
• Medical Benefit
• Care Team/Prescriber
• Health Plan
• Health System
• Specialty pharmacy
• Case manager
• Pharmacist
• Pharmaceutical company
• Patient assistance program
• Care Giver
• Home Care
Food for thought
9/12/2018
19
• Plans have more options for purchasing PBM services (e.g., bundled, unbundled, pass-through,
traditional, health system-owned, health plan owned, pharmacy-owned…)
• Medications are specializing, landscape is changing (specialty, medical pharmacy)
• Is current pharmacy program up to snuff?
Is Pharmacy Program Up to Snuff? Competitive?
Food for thought
• Plan’s motivation, desires for pharmacy program?
• Where will pharmacy program compete , be it’s best?
• How will pharmacy program be it’s best? • Please customers, provide sustainable value?
• What does map of capabilities look like?• What systems are required to support
services, measure outcomes?
Food for thought
What Decisions Might Need to be Made?
Key Takeaways from Learning Objectives- whew!• Understand core role of a Pharmacy Benefit Manager (PBM)
• Focused on cost reduction, access, AND Plan should eliminate PBM profit making incentives
• Learn about current state of affairs • Big PBMs dominate in PBM market share and pharmacy dispensing revenues! Conflict of interests exist. Payor could be
paying up to 30% more d/t PBMs favoring manufacturer and pharmacy relationships to retain profit margins.
• Understand how two main PBM contract types work and impact the Plan• Traditional Vs. Pass-through; Seek transparent, pass through contract. Ensure pass-through is actually performing as a
pass-through; measure performance by drug cost pmpm accounting for the maximum achievable discounts Vs. % discounts off a list price or variance to discount rates (flawed method)
• Speak to myths regarding ways to contract and manage PBM program• Big PBMs are not always better!; Mid-tier/smaller PBMs compete on price/service; Don’t assume cooperatives, carve-in
pharmacy, bundled contract is better on price and fit Vs. separate evaluation of vendors based on plans individual needs/fit
• Obtain a few tips on how to gain control of the PBM contract(s)• Seek trusted, knowledgeable advisor - help achieve contract that’s in full alignment to Plan’s best interest
• Explore how medical management might help pharmacy leaders to - address new challenges in pharmacy
• Provide oversight and expertise-ensure cost containment programs work in Plans favor• Explore pharmacy technology to help patients and providers achieve best outcomes• Gather and share with Plan insights from patient engagements
• Wind down with food for thought- is your pharmacy program up to snuff? • Many stakeholders involved w/ patient’s high cost medication taking experience/ decisions. Who’s providing the most
value to patients and outcomes? How do we optimize their work? What decisions do Plans need to make to ensure pharmacy program is competitive in a more specialized pharmacy market place.
9/12/2018
20
Thank you
Contact Information:[email protected]
List of PBMs
PBM Model Website State
MedImpact Healthcare Systems PBM, independent, full service http://www.medimpact.com CA
MedOne Healthcare Systems PBM Pharmacy ownership/ Hartig http://www.medonehs.com Iowa
MedTrak Services PBM http://www.medtrakrx.com KS
MeridianRx PBM, transparent http://www.meridianrx.com MI
National Pharmaceutical Services Now owned by Diplomat Specialty Pharmacy http://www.pti-nps.com NE
National Script PBM http://www.nationalscript.com CO
Navitus PBM, Transparent/Pass-through http://www.navitus.com WI
Northwest Pharmacy Services PBM http://www.NWPSRX.com WA
OptumRx PBM, traditional, United Health Group company http://www.optum.com IL
PDMI (Pharmacy Data Management) PBA http://www.pdmi.com OH
PerformRx PBM, owned by AmeriHealth Caritas (Medicaid focus) http://www.performrx.com PA
Phoenix Benefits Management PBM, TPA focus http://www.phoenixpbm.com GA
Prime Therapeutics PBM, Health Plan Owned (BCBS Plans) http://www.primetherapeutics.com MN
ProAct PBM, pass through, Pharmacy Ownership (Kinney) http://www.proactrx.com NY
ProCare Rx PBM PBM, transparent http://www.procarerx.com GA
RxAdvance PBM, technology focus http://www.rxadvance.com MA
ScriptGuideRX, Inc. PBM, transparent http:/www.scriptguiderx.com MI
Serve You Custom Rx Management PBM, self-funded employer focus http://www.serve-you-rx.com WI
WellDyneRx PBM http://www.welldynerx.com FL
History of PBM Mergers and Acquisition ActivityKey Drug firm
Drug-maker era: Pharmaceutical firms acquire PBMs
1968 The first PBM, Pharmaceutical Card Systems (PCS), is started in Scottsdale, Arizona
1993 Merck purchases Medco for $6 billion
1994 Eli Lilly purchases PCS Health Systems for $4 billion
1994 SmithKline Beecham buys Diversified Pharmaceutical Services (from insurer UnitedHealth) for $2.3 billion
Independent era: Pharmaceutical firms sell PBMs as a result of 1990s FTC actions
1998 Eli Lilly sells PCS Health Systems for $1.5 billion
1999 SmithKline Beecham sells Diversified Pharmaceutical Services to Express Scriptsfor $700 million
2003 Merck spins off Medco
Pharmacy era: Mergers between PBMs, and of PBMs with pharmacy chains
2000 Advance Paradigm purchases PCS for $1 billion, and becomes AdvancePCS
2003 Caremark purchases AdvancePCS for $5.6 billion
2007 CVS Purchases Caremark for $26.5 billion
2012 Express Scripts merges w/ Medco for $29 billion; acquires Accredo speciality pharmacy , merges it with CuraScript
Feb. 2015Rite Aid purchases EnvisionRx for $2 billion. (owns subsidiary PBM, MedTrak, owns PBMs Connect Health Solutions, Smith Premier Services)
Mar-15 OptumRx purchases Catamaran for $12.8 billion (combines 3rd & 4th-largest PBMs)
May-15 CVS purchases Omnicare for $12.7 billion
Oct. 2015 Walgreens announces intention to acquire Rite Aid for $17.2 billion
9/12/2018
21
Big PBMs % Rx Claims, 2015
Source: Drug Channels
Real Examples: PBM RFP Remove Profit-Making Opportunities from PBM Contract
Pseudo-Pass-Through Agreement- sneaky!
Real Examples: PBM RFPRemove Profit-Making Opportunities from PBM Contract
Boo!